Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavia Ferrantelli

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Biotechnology Journal|December 24, 2017
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral AntigensSimona Anticoli, Francesco Manfredi, Chiara Chiozzini, et al.
Microbes and Infection|October 26, 2005
Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 EnvBarbara Ensoli, Aurelio Cafaro, Antonella Caputo, et al.
Archives of Virology|May 6, 2017
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4<sup>+</sup> T lymphocytes and reactivation of the HIV-1 reservoirChiara Chiozzini, Claudia Arenaccio, Eleonora Olivetta, et al.
International Journal of Nanomedicine|July 12, 2017
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculationPaola Di Bonito, Chiara Chiozzini, Claudia Arenaccio, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade BMoiz Kitabwalla, Flavia Ferrantelli, Tao Wang, et al.
Cancer Gene Therapy|September 19, 2024
Extracellular vesicle-based anti-HOXB7 CD8<sup>+</sup> T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neuFlavia Ferrantelli, Francesco Manfredi, Micaela Donnini, et al.
Viruses|February 26, 2022
Strong SARS-CoV-2 N-Specific CD8<sup>+</sup> T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in MiceFlavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Problems and emerging approaches in HIV/AIDS vaccine developmentFausto Titti, Aurelio Cafaro, Flavia Ferrantelli, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 29, 2017
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cellsSimona Anticoli, Eleonora Aricò, Claudia Arenaccio, et al.
Vaccines|June 25, 2026
Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV ProteinsFrancesco Manfredi, Flavia Ferrantelli, Chiara Chiozzini, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Biotechnology Journal|December 24, 2017
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral AntigensSimona Anticoli, Francesco Manfredi, Chiara Chiozzini, et al.
Microbes and Infection|October 26, 2005
Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 EnvBarbara Ensoli, Aurelio Cafaro, Antonella Caputo, et al.
Archives of Virology|May 6, 2017
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4<sup>+</sup> T lymphocytes and reactivation of the HIV-1 reservoirChiara Chiozzini, Claudia Arenaccio, Eleonora Olivetta, et al.
International Journal of Nanomedicine|July 12, 2017
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculationPaola Di Bonito, Chiara Chiozzini, Claudia Arenaccio, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade BMoiz Kitabwalla, Flavia Ferrantelli, Tao Wang, et al.
Cancer Gene Therapy|September 19, 2024
Extracellular vesicle-based anti-HOXB7 CD8<sup>+</sup> T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neuFlavia Ferrantelli, Francesco Manfredi, Micaela Donnini, et al.
Viruses|February 26, 2022
Strong SARS-CoV-2 N-Specific CD8<sup>+</sup> T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in MiceFlavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, et al.
Expert Opinion on Emerging Drugs|March 16, 2007
Problems and emerging approaches in HIV/AIDS vaccine developmentFausto Titti, Aurelio Cafaro, Flavia Ferrantelli, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 29, 2017
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cellsSimona Anticoli, Eleonora Aricò, Claudia Arenaccio, et al.
Vaccines|June 25, 2026
Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV ProteinsFrancesco Manfredi, Flavia Ferrantelli, Chiara Chiozzini, et al.
Pageof 5